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Background: Regulation of cell death during neurodegeneration is one of the key factors that play a role in the
speed at which a disease progresses. Out of several cellular pathways responsible for this progression, necrosis and
apoptosis are situated on the opposite spectrum of cell death regulation. Necrosis produces an environment that
promotes inflammation and cytotoxicity and apoptosis is a highly organized process that maintains tissue
homeostasis. A recently discovered protein, Nlrx1, regulates inflammatory and cell death responses during infection.
Findings: Using transfections of N2A cell line, we demonstrate that Nlrx1 redirects cells away from necrosis and
towards an apoptotic pathway following rotenone treatments. In addition, Nlrx1 promotes DRP1 phosphorylation
and increases mitochondrial fission.
Conclusion: Our results suggest a novel molecular pathway for regulating mitochondrial dynamics and neuronal
death. Nlrx1 may play an important role in neurodegenerative diseases, where necrosis is a prominent factor.
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Neuronal cell death is a fundamental process that
governs development and homeostasis of the central
nervous system (CNS) [1]. During development many
neurons die off in the process of pruning, which leaves
only those neurons that have meaningful connections.
Throughout adult life, neurons have to survive under
constant environmental stress such as toxins, infections,
and inflammatory mediators. Inability to cope with these
stimuli results in neuronal cell death and neurodegeneration
that lead to neurological dysfunction [2]. There are three
major types of cell death: necrosis, apoptosis, and
autophagy. Necrotic cell death is the least controlled
process that triggers cellular pathways, which leads to
bursting of cells and leakage of the internal materials
(such as HMGB1) in the extracellular environment.
This leakage is highly cytotoxic and induces robust
pro-inflammatory responses. Apoptosis is an organized
step-like process that initiates with nuclear condensation,
membrane blebbing, and leads to formation of apoptotic
bodies that are phagocytized by microglia and astrocytes.
Finally, autophagy may be considered a cell survival
pathway as it mobilizes cell resources in response toCorrespondence: denis.gris@usherbrooke.ca
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hypoxia, etc. Driven to extreme, autophagy may lead
to cell death [3]. Remarkably, mitochondria is situated
at the crossroads of all three pathways, and thus
regulate the balance between the three types of cell
death [4]. Mitochondria are well known for their
ability to induce apoptosis by releasing cytochrome c
and by activating downstream caspases. In addition,
mitochondrial fusion and fission are critical to the
survival of neurons. Interestingly, mitochondrial fission
was shown to be protective during ischemia and during
Huntington’s disease [5].
Inflammation is an integral part of the tissue response
to any kind of cell death. This response may become
cytotoxic and even damaging to surrounding cells
depending on the milieu. For example, during infection
or tissue damage, microglia and astrocytes are activated
by pathogen-associated molecular patterns (PAMPs) and
danger associated molecular patterns (DAMPs). Once
activated, these cells release cytokines and chemokines
that attract more inflammatory cells. In addition, they
release reactive oxygen and nitrogen species thus,
increasing the cytotoxicity of the environment and leading
to excessive neuronal cell death. The concentrations and
compositions of PAMPs and DAMPs are monitored
by sensors and receptors including Toll-like receptors
(TLRs), NOD-like receptors (NLRs), RIG-I helicasesal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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regulate intestinal homeostasis, regulating susceptibility to
inflammatory bowel diseases and cancer [8].
Of these receptors, Nlrx1, belongs to the NLR family
of intracellular sensors that regulate major cellular
pathways including cell death and inflammation. Previous
research implicated Nlrx1 in the regulation of autophagy
and reactive oxygen species production during viral infec-
tion [9]. In addition, most recent publications implicated
Nlrx1 in the regulation of cell death, gastritis, and colon
cancer [10-13]. Moreover, we demonstrate that Nlrx1
modulates neuronal apoptosis by regulating mitochondrial
fission.Materials and methods
Chemical reagents
BRD, Mdivi, staurosporine, and rotenone were purchased
from Sigma-Aldrich. Z-VAD FMK was purchased from
R&D systems. MitoTracker Mitochondrion-Selective
Probes were purchased from Invitrogen. Trizol was
purchased from Life Technologies. M-MLV Reverse
Transcriptase and RNasin Ribonuclease Inhibitor were
purchased from Promega. Oligo(dT) primer was purchased
from Fermentas Life Sciences and PCR Nucleotide
Mix was purchased from GE Healthcare. Brilliant III
Ultra-Fast SYBR Green QPCR Master Mix was pur-
chased from Agilent Technologies. α/β-Tubulin rabbit,
cleaved caspase-3 rabbit, DRP1 rabbit, phospho-DRP1
(Ser616) rabbit, HSP90 Rabbit, HMGB1 Rabbit,
COX IV Rabbit, and anti-rabbit IgG HRP-linked
antibodies were purchased from Cell Signaling Tech-
nology. Nlrx1 polyclonal antibody was purchased
from Proteintech.Cell culture and cell lines
All cell lines were generated on the basis of mouse
neuroblastoma (N2A) cells. Nlrx1 stable Knock-In N2A
cells were generated using Origene TrueORF cDNA
Clone Nlrx1 vector system with TurboFectin. Nlrx1
stable Knock-Down cells were generated using Origene
ShRNA plasmid against Nlrx1. The vector contains a
tGFP gene, which expresses tGFP constitutively in
mammalian cells. Transfection stable control was generated
using a GFP Scrambled ShRNA from Origene. Nlrx1
Knock-In GFP positive cells were selected with neomycin
and Nlrx1 GFP positive Knock-Down and Scrambled were
selected with puromycin. Real time Quantitative PCR and
RT-PCR was used to verify expression of Nlrx1. Primers
sequences Nlrx1 F: 5′-CCT CTG CTC TTC AAC TTG
CTC-3′, Nlrx1 R: 5′-CCC ATC TGA TCC AGA ACA
TCG-3′, 18S F: 5′-CGG CTA CCA CAT CCA AGG AA-3′,
18S R: 5′-GCT GGA ATT ACC GCG GCT-3′ were
purchased from IDT.Experimental procedures
Western blotting
Membranes were incubated with primary antibody
(1:1000) overnight at 4°C and secondary (1:2000) for
2 hours at room temperature.
Cell death assay
Cell death was detected by LDH release with a microtiter
plate based colorimetric absorbance assay that was
developed based on a protocol from Chan and al, 2013.
Flow cytometry
Mitochondrial mass was evaluated using Mitotracker
Mitochondrion-Selective Probes. 2×105 cells were re-
suspended in 200 μl of media containing 100 nm of
Mitotracker and were incubated at 37°C for 20 minutes.
Samples were analyzed by flow cytometry using a FACS
Calibur. Data were analyzed using FlowJo software.
Electron microscopy
Cells were fixed using standard protocol by glutaraldehyde
in sodium cacodylate followed by osmic acid and Epon
3 impregnation. Images were collected using Hitachi
H-7500.
Statistical analyses
Mean values were compared using Two-way ANOVA
followed by Tukes’ test for comparison; significance was
accepted at p < 0.05.
Results
To investigate the role of Nlrx1 in neuronal death, we
generated Knock-In (KI) and Knock-Down (KD) N2A
stable cell lines, which expressed high or low amounts of
Nlrx1 respectively. Cells transfected with scrambled
ShRNA (Sc) served as controls. First, we validated the
expression pattern of Nlrx1 in different cell lines. We
observed significant increase of expression of Nlrx1
protein and Nlrx1 mRNA levels in KI cells compared
to cells transfected with empty vector (Figure 1A, B,
and C). In cells that were transfected with Nlrx1
ShRNA, we saw two-fold reduction of Nlrx1 protein and
mRNA expression. Nlrx1 was localized to mitochondria,
but not to lysosomes (Figure 1D).
Cells were then treated with rotenone; a compound
acting on mitochondrial respiration (it blocks complex I
of the mitochondrial respiratory chain) and also it is
implicated in the etiology of Parkinson’s disease. The
release of lactate dehydrogenase was quantified, which
upon cell death leaks out of the cells and into the
supernatant/cell culture medium. We observed a signifi-
cant rotenone dose-dependent increase in cell death in all
cell lines. In addition, we noted a dose-dependent protec-
tion effect of Nlrx1, where Nlrx1 KI cells were the least
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Figure 1 Nlrx1 expression in N2A cells. (A) Representative photograph of Immunoblotting of KI, KD, and Sc cells, molecular weight of endogenous
Nlrx1 is 108 kDa. In KI cells Nlrx1-GFP is around 130 kDa. (B) Nlrx1 protein expression in KI, KD, and Sc cells, n = 3. (C) Nlrx1 mRNA expression in KI
(Nlrx1GFP), KD (shNlrx1), and Sc (Sh Scramble), n = 5. (D) Localization of Nlrx1 protein to mitochondria showing that Nlrx1 co-localized with mitochondria,
but not with lysosomes. Photomicrographs of confocal images of cells labeled green for Nlrx1 and stained with mitotracker or lysotracker (red). Overlay
showing co-localisation of Nlrx1 and mitotracker or with lysotracker (orange). * p < 0.0001.
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cell line. The KD cell line, with decreased levels of Nlrx1,
was the most vulnerable to rotenone treatments
(Figure 2A). The addition of BRD (ROS enhancer
[14]) to the rotenone treatment resulted in increased
levels of released LDH. The relationship between the
cell lines remained similar to rotenone treatment.
When we used pan-caspase inhibitor Z-VAD, we observed
a significant reduction of cell death in all cell lines except
for Nlrx1 KD (Figure 2B). We used staurosporine as
one of the widely used reagents that induces cell
death via intrinsic apoptotic pathway. We noticed asignificant induction of LDH release in all cell lines
(Figure 2C). We did not observe significant differences in
LDH release between different cell lines at 1 μM concen-
tration of staurosporine. At 0.5 μM staurosporine, KI cells
released significantly more LDH.
The release of LDH is an indirect indicator of cell
mortality; therefore, we used Western blotting for active
cleaved-caspases-3 in cell lysates as an indicator of the
degree of apoptosis. HSP90 and HMGB1 presence in cell
culture medium were used as indicators of necrosis. The
basal levels of HSP90 and HMGB1 were significantly
higher in KD cell line after 24 hours of 100 μM rotenone
Figure 2 Nlrx1 protects from rotenone-induced cell death. (A) Cells were treated with 10 μM and 100 μM rotenone for 24 hours, n = 3.
(B) Cells were treated for 24 h with 100 μM rotenone 100 μM Z-VAD FMK, and 40 μM BRD, n = 3. (C) Staurosporine treatment for 24 h kills all cells
equally with exception of Nlrx1 KI cells at 0.5 μM concentration, n = 3. (D) Western blotting for markers of necrosis HSP90 and HMGB1 and marker
of apoptosis active cleaved-caspase-3. * p < 0.001.
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activated caspase-3 and HMGB1 as well as HSP90 in KI
cells compared to Sc and KD cell lines (Figure 2D).
Furthermore, to evaluate cell viability and the degree
of apoptosis, we used flow cytometry of annexin V/PI
stained cells (Figure 3A). We observed a significant
decrease in live cells after rotenone treatment (Figure 3B).
KI cells were significantly more resistant to the rotenone
treatment. Thus, to understand the balance between
necrosis and apoptosis in cells following rotenoneFigure 3 After rotenone treatment, overexpression of Nlrx1 increases
necrosis. Flow cytometric analysis of annexin V-PI staining of cells treated
plots of annexin V/PI stained cells. Annexin V negative PI negative quadran
at the early apoptotic stages, and annexin positive I positive defines cells th
of three independent experiments. (C) Graphical representation of ratios of n
different from Sc p < 0.01.treatment, we evaluated the ratio of cells in the upper
right quadrant, which defines cells in the stage of late
apoptosis or necrosis, to the cells in lower right quadrant,
which defines cells in early stages of apoptosis. We found
that the ratio in KD compared to KI cells was significantly
higher (Figure 3C).
Hence, we hypothesised that mitochondrial localisation
may enable Nlrx1 to regulate mitochondrial dynamics.
Using electron microscopy (Figure 4A and B) and flow
cytometry (Figure 4C and D), we observed an increasedcell viability and shifts cell death to apoptosis rather than
with 10 μM rotenone for 24 hours. (A) Representative flow cytometry
t defines live cells, annexin V positive PI negative defines cells that are
at undergo necrosis or in the late apoptotic stages. (B) Quantifications
ecrotic/late apoptotic cells to early apoptotic cells, n = 3. * Significantly
Figure 4 Nlrx1 promotes mitochondrial fission. Photomicrographs showing mitochondrial content. (A) KD Nlrx1 cells have a decreased
mitochondrial number. (B) KI Nlrx1 cells have more mitochondria and those mitochondria have swollen cristae. * represent mitochondria, scale
bar is 500 nm. (C) There is a higher mitochondrial mass in KI Nlrx1 cells compared to KD Nlrx1 cells as showed by Mitotracker red staining in GFP
positive cells, n = 3. (D) Representative plot of flow cytometry experiment with Mitotracker red staining showing a higher mitochondrial mass in
KI Nlrx1 cells compared to KD Nlrx1 cells.
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as well as to control cells. Additionally, KI cells’ mitochon-
dria were swollen and had less cristae (Figure 4A and B).
The process of increasing mitochondrial number is called
fission and is governed by multiple proteins including
DRP1. DRP1, in particular, mediates fission upon phos-
phorylation of Ser616. We verified the expression and
phosphorylation status of DRP1 in different cell lines
and observed significant increases in phosphorylation
of DRP1 in KI compared to KD and to control cells
(Figure 5A and B). Then, we performed immunoprecipita-
tion using antibodies against DRP1 and P-DRP1 in orderFigure 5 Nlrx1 associates with DRP1. (A) Immunoblotting of DRP1 and
(B) Quantification of phospho-DRP1 normalised to total DRP1. There is mo
shRNA and Sc cells. (C) Immunoprecipitation of Nlrx1 and DRP1, but not o
antibody in lane 5 and 6; and with anti-DRP1 antibody lane 3 and 4; and a
and 6 contain IP fractions, and lane 7 contains total protein lysate. The We
from Sc, p < 0.05.to pull DRP1; and we used anti-GFP to pull Nlrx1.
We then probed blots with anti-DRP1, anti-P-DRP1,
anti-Nlrx1, anti-COX IV (mitochondrial protein), and
anti-HSP90 antibodies. We observed an association
whenever we used anti-DRP1, anti-P-DRP1, and Nlrx1
antibodies, but not when anti-COX IV and HSP90
were used (Figure 5C).
These results, so far, suggest that Nlrx1 may regulate cell
survival by associating with DRP1 and thus augmenting
mitochondrial fission. To verify DRP1-dependent effect of
Nlrx1, we treated all cell lines with Mdivi, a DRP1 inhibi-
tor, in addition to rotenone treatment. Using LDH assay,Phosphorylated DRP1 at serine 616 in Sc, KI, and KD N2A cells.
re phosphorylated DRP1 at Ser616 in KI Nlrx1 cells compared to KD
f Nlrx1 and HSP90 or COX IV. Co-immunoprecipitation with anti-tGFP
nti-P-DRP1 lane 1 and 2. Lane 1, 3, and 5 contain supernatant; lane 2, 4
stern blot was probed with anti-DRP1 antibody. * Significantly different
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cells, but had little effect in KD cells (Figure 6A).
These results were confirmed by Western blotting,
where we observed a significant induction of necrosis in
KI cells after combined Mdivi and rotenone treatment
(Figure 6B). Furthermore, Mdivi treatment equalized the
amount of live cells and ratios of necrotic to apoptotic
cells across all cell lines (Figure 6C, D, and E).
Discussion
The field of NLR biology is young and the majority of
research has been directed towards the role of NLRs in
the host-pathogen interaction. Nlrx1 is one of the few
NLRs that, in addition to mediating the immune
response, regulates cell death in multiple cell types. In this
report, we provide evidence that Nlrx1 controls cell death
by regulating the mitochondrial homeostasis. In particular,
we found that Nlrx1 augments mitochondrial fission that
protects cells from the rotenone toxicity. We found that
Nlrx1 protects N2A cells during necrosis-like cell death
but not against reagents like staurosporine that potentially
induce apoptotic cell death. While in absence of Nlrx1,
cells are more protected against apoptosis-inducing
stimuli, they are more sensitive to necrosis. In decipheringFigure 6 DRP1 inhibitor Mdivi contracts Nlrx1 protective effect after r
treatments with 100 μM rotenone and 50 μM Mdivi for 24 hours, n = 3. (B)
supernatants after rotenone and Mdivi treatments. (C) Representative flow
50 μM Mdivi. (D) Quantifications of three independent experiments. (E) Gra
apoptotic cells. * Significantly different from Sc, p < 0.05.Nlrx1’s molecular pathway, we found that Nlrx1 associates
with DRP1, which augments mitochondrial fission and
thus saves cells from necrosis. Indeed, the inhibition of
DRP1 resulted in loss of Nlrx1-mediated protection
during rotenone-induced cell death.
Overexpression of Nlrx1 in N2A cells significantly
reduced rotenone-mediated cell death, while reduction of
Nlrx1 made cells more vulnerable to rotenone toxicity.
Previous research suggested that Nlrx1 may mediate ROS
production [15,16]. We used BRD treatment that enhances
non-toxic ROS production. Although this treatment
increased rotenone-dependent cell death, the effect in the
different cell lines was similar, which suggests that mecha-
nisms of Nlrx1 neuroprotection are not ROS dependent.
Rotenone can induce mitochondrial dysfunction, increase
in ROS production, and an increase in caspases-dependent
apoptosis. At the same time, cytotoxic events within cells
initiate necrosis [17-19]. Our results suggest that Nlrx1
inhibits both rotenone-induced necrosis and apoptosis.
Indeed, after rotenone treatment, we observed reduced
presence of HSP90 and HMGB1 in the supernatants from
KI cells compared to KD cells. In KD cells, low levels of
Nlrx1 allowed cell to shift towards necrosis, which was
most notable when apoptosis was inhibited by Z-VAD.otenone treatments. (A) Quantification of released LDH assay after
Representative Immunoblotting of HMGB1 and HSP90 in cell culture
cytometry plots of KI and KD cells treated with 10 μM rotenone and
phical representation of ratios of necrotic/late apoptotic cells to early
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from Girardin group who found that Nlrx1 accelerates
intrinsic apoptotic pathway [10]. In that paper, Nlrx1
augmented intrinsic apoptotic pathway while inhibiting
TNF cyclohexamide-sensitive cell death. In a different
report, authors demonstrated that TNF may induce
necrotic programed cell death mediated through TNFRI
RIP2 TRAF2 [20]. Allen et al. demonstrated that viral
infection induces Nlrx1-mediated autophagy in cells.
Interestingly, another recent report found that Nlrx1
protects macrophages by blocking the function of the
viral proteins that induce apoptosis. Another group
demonstrated that Nlrx1 is mediating virally-induced
autophagy, but they did not report an effect of Nlrx1 on
cell death [21]. Our work suggests that in the absence of
viral infection, Nlrx1 redirects cellular stress towards
apoptosis thus, protecting cells from necrosis-like
cell death. We did not notice any physiological or
biochemical differences between Nlrx1 KI and Nlrx1
KD cells at basal level suggesting that Nlrx1 functions are
triggered only during stressful conditions. These results
are collaborated by multiple studies with Nlrx1 KO mice.
Although, Nlrx1 has been implicated in many cellular
pathways, Nlrx1 KO mice are viable and fertile and
do not show any deviations from WT mice at the
basal conditions [16,22-24].
Several groups have shown Nlrx1 to localize to mito-
chondria, although the exact distribution of Nlrx1 within
the inner and outer mitochondrial membrane is still
under debate.
Electron microscopy studies enforced by flow cytome-
try experiments suggest an increased number of mito-
chondria in Nlrx1 KI cells. We demonstrated that
increase in Nlrx1 expression resulted in augmented
mitochondrial fission with an upsurge in phosphorylated
levels of DRP1. Several reports suggest that Nlrx1 may
bind and regulate functions of mitochondria-localized
proteins including MAVS and UQCRC2 [25,26]. The
exact molecular pathway that phosphorylates DRP1 is
still under investigation. Overexpressing Nlrx1 resulted
in the increased number of mitochondria, but these
mitochondria had a reduced number of cristae of which
all were swollen, which suggests that excessive fission
induced mitochondrial stress. In our opinion, those
mitochondria are more sensitive to cytotoxic events,
which explains why Nlrx1 KI cells were more sensitive to
some of the apoptosis inducing reagents. This observation
is collaborated by several studies, which evaluate
mitochondrial function in cell death. A dysfunction of
DRP1 and altered mitochondrial fission led to a
switch from apoptotic to necrotic cell death [27]. In
addition, an increase in mitochondrial fission has been
implicated in the etiology of neuronal cell death in
Huntington’s disease [5].In conclusion, to our knowledge this work describes
for the first time the involvement of Nlrx1 in mitochon-
drial dynamics during neuronal death. We would like to
note that these experiments were conducted in N2A
transformed cells lines and that these cells possess
neuronal-like properties. Future studies will confirm
this observation in primary neuronal cultures and in
transgenic mice.
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